Gsk (GSK) Income from Non-Controlling Interests (2016 - 2025)
Historic Income from Non-Controlling Interests for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.
- Gsk's Income from Non-Controlling Interests rose 332475.32% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 billion, marking a year-over-year increase of 5233.09%. This contributed to the annual value of $480.6 million for FY2024, which is 168.81% up from last year.
- According to the latest figures from Q3 2025, Gsk's Income from Non-Controlling Interests is $2.9 billion, which was up 332475.32% from $2.2 billion recorded in Q2 2025.
- Over the past 5 years, Gsk's Income from Non-Controlling Interests peaked at $4.2 billion during Q4 2023, and registered a low of $23.6 million during Q3 2022.
- For the 5-year period, Gsk's Income from Non-Controlling Interests averaged around $1.4 billion, with its median value being $1.4 billion (2024).
- Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first plummeted by 9737.04% in 2021, then surged by 814359.23% in 2023.
- Over the past 5 years, Gsk's Income from Non-Controlling Interests (Quarter) stood at $269.6 million in 2021, then surged by 100.13% to $539.5 million in 2022, then soared by 676.6% to $4.2 billion in 2023, then dropped by 9.61% to $3.8 billion in 2024, then fell by 23.64% to $2.9 billion in 2025.
- Its Income from Non-Controlling Interests was $2.9 billion in Q3 2025, compared to $2.2 billion in Q2 2025 and $2.2 billion in Q1 2025.